Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes

Nephrology Dialysis Transplantation

Volumn 25, Issue 8, 2010, Pages 2479-2486

  Yang, Rui ^a   Otten, Marielle A ^b   Hellmark, Thomas ^c   Collin, Mattias ^c   Björck, Lars ^c   Zhao, Ming Hui ^a   Daha, Mohamed R ^b   Segelmark, Mårten ^c  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LUND UNIVERSITY   (Sweden)

Author keywords

anti GBM disease; EndoS; Goodpasture's disease; IdeS

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; ENDOGLYCOSIDASE S; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G DEGRADING ENZYME OF STREPTOCOCCUS PYOGENES; IMMUNOMODULATING AGENT; STREPTOCOCCUS ANTIGEN; UNCLASSIFIED DRUG; ANTIGLOMERULAR BASEMENT MEMBRANE ANTIBODY; AUTOANTIBODY; BACTERIAL PROTEIN; GLYCOSIDASE; MAC-1-LIKE PROTEIN, STREPTOCOCCUS; NDOS PROTEIN, STREPTOCOCCUS PYOGENES;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; GLOMERULONEPHRITIS; GLOMERULUS; HISTOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY INJURY; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; PATHOLOGY; TREATMENT OUTCOME;

ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOANTIBODIES; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; GLYCOSIDE HYDROLASES; IMMUNOGLOBULIN G; KIDNEY GLOMERULUS; MALE; MICE; MICE, INBRED C57BL; TREATMENT OUTCOME;

EID: 77954788863     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq115     Document Type: Article

References (18)

1. Albert H, Collin M, Dudziak D et al. In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG sub- class-dependent manner. Proc Natl Acad Sci USA 2008; 105: 15005-15009
2. Allhorn M, Olsen A, Collin M. EndoS from Streptococcus pyogenes is hydrolyzed by the cysteine proteinase SpeB and requires glutamic acid 235 and tryptophans for IgG glycan-hydrolyzing activity. BMC Microbiol 2008; 8: 3
3. Beck LH Jr., Bonegio RG, Lambeau G et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11-21
4. Collin M, Olsen A. Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect Immun 2001; 69: 7187-7189
5. Collin M, Olsen A. EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBO J 2001; 20: 3046-3055
6. Collin M, Shannon O, Bjorck L. IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions. Proc Natl Acad Sci USA 2008; 105: 4265-4270
7. Hudson BG, Tryggvason K, Sundaramoorthy M. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 2003; 348: 2543-2556
8. Jayne DR, Gaskin G, Rasmussen N. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007; 18: 2180-2188
9. Johansson BP, Shannon O, Bjorck L. IdeS: a bacterial proteolytic enzyme with therapeutic potential. PLoS One 2008; 3: e1692
10. Nandakumar KS, Collin M, Olsen A. Endoglycosidase treatment abrogates IgG arthritogenicity: importance of IgG glycosylation in arthritis. Eur J Immunol 2007; 37: 2973-2982
11. Nandakumar KS, Johansson BP, Bjorck L. Blocking of experimental arthritis by cleavage of IgG antibodies in vivo. Arthritis Rheum 2007; 56: 3253-3260
12. Otten MA, Groeneweld TWL, Flierman R. Both complement and IgG Fc receptors are required for development ofattenuated anti-glomeru- lar basement nephritis in mice. J Immunol 2009; 183: 3980-3988
13. Salama AD, Levy JB, Lightstone L. Goodpasture's disease. Lancet 2001; 358: 917-920
14. Segelmark M, Hellmark T, Wieslander J. The prognostic significance in Goodpasture's disease of specificity, titre and affinity of anti-glo- merular-basement-membrane antibodies. Nephron Clin Pract 2003; 94: c59-c68
15. Vincents B, von Pawel-Rammingen U, Bjorck L. Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding. Biochemistry 2004; 43: 15540-15549
16. von Pawel-Rammingen U, Johansson BP, Bjorck L. IdeS, a novel streptococcal cysteine proteinase with unique specificity for immuno- globulin G. EMBO J 2002; 21: 1607-1615
17. Wenig K, Chatwell L, von Pawel-Rammingen U. Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG. Proc Natl Acad Sci USA 2004; 101: 17371-17376
18. Yang R, Hellmark T, Zhao J. Levels of epitope-specific autoantibo- dies correlate with renal damage in anti-GBM disease. Nephrol Dial Transplant 2009; 24: 1838-1844.